We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Slaps Abraxis Plant With Warning Letter for Contamination Issues
FDA Slaps Abraxis Plant With Warning Letter for Contamination Issues
Because Abraxis Bioscience, a subsidiary of BMS, didn’t fix the problem of multiple media fill failures along the aseptic processing line at its biologics plant, the FDA hit the Phoenix, Ariz., company with a warning letter.